200,000+ products from a single source!

sales@angenechem.com

Home > Fluorides > 155204-26-5

155204-26-5

155204-26-5 | Benzamide, 4-fluoro-N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-

CAS No: 155204-26-5 Catalog No: AG001NQB MDL No:

Product Description

Catalog Number:
AG001NQB
Chemical Name:
Benzamide, 4-fluoro-N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-
CAS Number:
155204-26-5
Molecular Formula:
C25H27FN4O2
Molecular Weight:
434.5059
IUPAC Name:
4-fluoro-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylbenzamide
InChI:
InChI=1S/C25H27FN4O2/c1-32-23-7-3-2-6-22(23)29-17-14-28(15-18-29)16-19-30(24-8-4-5-13-27-24)25(31)20-9-11-21(26)12-10-20/h2-13H,14-19H2,1H3
InChI Key:
YJZYDPRMWYWYCG-UHFFFAOYSA-N
SMILES:
COc1ccccc1N1CCN(CC1)CCN(C(=O)c1ccc(cc1)F)c1ccccn1
UNII:
81KHI46E5L

Properties

Complexity:
578  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
434.212g/mol
Formal Charge:
0
Heavy Atom Count:
32  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
434.515g/mol
Monoisotopic Mass:
434.212g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
48.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.9  

Literature

Title Journal
Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 20120101
Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study. Biological psychiatry 20081201
Activation of the serotonergic 5-HT1A receptor in the paraventricular nucleus of the hypothalamus inhibits water intake and increases urinary excretion in water-deprived rats. Regulatory peptides 20081009
Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain : a journal of neurology 20081001
PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain : a journal of neurology 20081001
Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist. British journal of pharmacology 20071101
Analysis of 18F-labelled synthesis products on TLC plates: comparison of radioactivity scanning, film autoradiography, and a phosphoimaging technique. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20060901
Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats. Nuclear medicine and biology 20060701
Prolonged treatment with ligands affects ligand binding to the human serotonin(1A) receptor in Chinese hamster ovary cells. Cellular and molecular neurobiology 20060501
Cholesterol modulates the antagonist-binding function of hippocampal serotonin1A receptors. Biochimica et biophysica acta 20050801
The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens. European journal of pharmacology 20050131
G-protein-dependent cell surface dynamics of the human serotonin1A receptor tagged to yellow fluorescent protein. Biochemistry 20041221
Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study. Biological psychiatry 20041015
5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain : a journal of neurology 20040401
Ligand binding characteristics of the human serotonin1A receptor heterologously expressed in CHO cells. Bioscience reports 20040401
Displacement of the PET ligand 18F-MPPF by the electrically evoked serotonin release in the rat hippocampus. Synapse (New York, N.Y.) 20030915
An in vitro assay for predicting successful imaging radiotracers. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20030101
5-HT(1A) receptor imaging in the human brain: effect of tryptophan depletion and infusion on [(18)F]MPPF binding. Synapse (New York, N.Y.) 20021101
5-HT1A receptor-mediated regulation of mitogen-activated protein kinase phosphorylation in rat brain. European journal of pharmacology 20021004
Regulation of the avidity of ternary complexes containing the human 5-HT(1A) receptor by mutation of a receptor contact site on the interacting G protein alpha subunit. British journal of pharmacology 20021001
The potential of the beta-Microprobe, an intracerebral radiosensitive probe, to monitor the [(18)F]MPPF binding in the rat dorsal raphe nucleus. European journal of nuclear medicine and molecular imaging 20020901
Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20020601
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
Quantification of 5-HT(1A) receptors in human brain using p-MPPF kinetic modelling and PET. European journal of nuclear medicine and molecular imaging 20020101
Comparative study of hippocampal neuronal loss and in vivo binding of 5-HT1a receptors in the KA model of limbic epilepsy in the rat. Epilepsy research 20011101
Modulation of antagonist binding to serotonin1A receptors from bovine hippocampus by metal ions. Cellular and molecular neurobiology 20011001
On the quantification of [18F]MPPF binding to 5-HT1A receptors in the human brain. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20010701

© 2019 Angene International Limited. All rights Reserved.